Transaction DateRecipientSharesTypePriceValue
25th November 2020Christopher Bischoff713Exercise of derivative$0.00
25th November 2020Sandra L Fenwick7,173Exercise of derivative$0.00
25th November 2020Karen L Daniel7,173Exercise of derivative$0.00
30th October 2020Hemant Taneja7,922Other acquisition or disposition$0.00
30th October 2020Hemant Taneja982,160Disposition due to a tender of shares in a change of control transaction$0.00
30th October 2020Hemant Taneja13,943,216Disposition due to a tender of shares in a change of control transaction$0.00
30th October 2020Catalyst Group Management Holdings Gp, Llc General982,160Disposition due to a tender of shares in a change of control transaction$0.00
30th October 2020Catalyst Group Management Holdings Gp, Llc General7,922Other acquisition or disposition$0.00
30th October 2020Hemant Taneja14,048Disposition due to a tender of shares in a change of control transaction$0.00
30th October 2020Catalyst Group Management Holdings Gp, Llc General2,892,681Disposition due to a tender of shares in a change of control transaction$0.00
Livongo Health
Livongo Health logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 6/10.


Livongo Health, Inc. develops and operates a consumer digital health platform. It focuses on diabetes, hypertension, weight management, diabetes prevention, and behavioral health. The company was founded by Kimon Angelides and Glen E. Tullman on October 16, 2008.


Ticker: LVGO
Sector: Technology Services
Industry: Packaged Software
SEC Central Index Key (CIK): 1639225
Employees: 615
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $686 M (0%)
Inventory, Net: $18 M (-39%)
Other Assets, Current: $0 (-100%)
Assets, Current: $951 M (95%)
Property, Plant and Equipment, Net: $16 M (0%)
Other Assets, Noncurrent: $569 Th (0%)
Assets: $1 B (87%)
Accounts Payable, Current: $6 M (-23%)
Accrued Liabilities, Current: $36 M (0%)
Liabilities, Current: $48 M (14%)
Other Liabilities, Noncurrent: $397 Th (-86%)
Liabilities: $471 M (785%)
Common Stock, Value, Issued: $100 Th (5%)
Retained Earnings (Accumulated Deficit): $171 M (0%)
Stockholders' Equity (Parent): $578 M (0%)
Liabilities and Equity: $1 B (87%)
Revenue: $92 M (-42%)
Cost of Revenue: $21 M (-45%)
Gross Margin: $70 M (-41%)
Research and Development: $16 M (-46%)
Sales and Marketing: $33 M (-45%)
General and Administrative Expenses: $22 M (-41%)
Operating Income/Loss: $262 Th (-96%)
Provision for income taxes: $72 Th (-22%)